MetaCap

Curanex Pharmaceuticals (CURX) vs Cadrenal Therapeutics (CVKD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cadrenal Therapeutics is the larger company by market cap ($7.0 million vs $6.9 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CURX-7.54%CVKD+74.84%
+99%+42%-15%
Oct 7, 20261 yearNov 20, 2026
CURX-16.94%CVKD+86.79%
+92%+35%-22%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CURX versus CVKD key metrics
MetricCURXCVKD
Share price$4.41$1.70
Market cap$6.92M$7.01M
1-day change-0.67%+0.59%
EPS (TTM)$-8.78$-3.67
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-4.23M$-13.24M
52-week high$13.34$12.50
52-week low$3.58$0.816
Distance from 52-week high-66.94%-86.40%
Analyst consensus—none
Avg. price target upside—+723.53%
Average volume17.83K496.14K
Shares outstanding1.57M4.12M
Employees65
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Curanex Pharmaceuticals

CURX stock →

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

About Cadrenal Therapeutics

CVKD stock →

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

CURX vs CVKD FAQ

Which is bigger, Curanex Pharmaceuticals or Cadrenal Therapeutics?

Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $7.01M compared with $6.92M for Curanex Pharmaceuticals (CURX).

Are Curanex Pharmaceuticals and Cadrenal Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons